Reuters logo
BRIEF-Hamlet Pharma completes preclinical studies in two animal models
July 21, 2017 / 9:05 AM / 4 months ago

BRIEF-Hamlet Pharma completes preclinical studies in two animal models

July 21 (Reuters) - HAMLET PHARMA AB

* HAMLET PHARMA HAS SUCCESSFULLY CONDUCTED PRECLINICAL TOXICOLOGY/SAFETY STUDIES IN TWO DIFFERENT ANIMAL MODELS

* RESULTS SHOW THAT ALPHA1H IS WELL TOLERATED AND CAUSES NO LOCAL TOXICITY Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below